![]() Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | ![]() Cantex Pharmaceuticals Cantex Pharmaceuticals is a pharmaceutical company developing proprietary pharmaceuticals that improve the treatment of cancer. | ![]() Oncoceutics Oncoceutics was a biotechnology company that developed small molecule compounds targeting G protein-coupled receptors for oncology applications. | |||
Founding Date | Founding Date 1997 | Founding Date 2008 | Founding Date 1781 | Founding Date 2002 | Founding Date 2009 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Memphis, US HQ | Locations Gothenburg, SE HQ | Locations Weston, US HQ | Locations Philadelphia, US HQ | |
Employees | Employees 1148% decrease | Employees 5 | Employees 47,4554% decrease | Employees 650% increase | Employees 12 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 57.2 m | Valuation ($) 43.7 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $4.3m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥818.8b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥3.8t (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($31.3m) (FY, 2021) | Net income (kr54.2m) (FY, 2025) | Net income ¥108.1b (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 64.7m | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised $ 27.4m | Total funding raised N/A |

Isofol Medical is a biotech company that focuses on a cancer drug.
View company
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company
Cantex Pharmaceuticals is a pharmaceutical company developing proprietary pharmaceuticals that improve the treatment of cancer.
View company
Oncoceutics was a biotechnology company that developed small molecule compounds targeting G protein-coupled receptors for oncology applications.
View company